{
    "success": true,
    "data": {
        "leverage": true,
        "derivatives": true,
        "swaps": true,
        "inverse": false,
        "replication_method": "synthetic",
        "ucits": true,
        "type": "ETP",
        "complex_factors": [
            "Leverage (2x daily)",
            "Daily compounding effect",
            "Synthetic replication (uses futures/swaps)",
            "Counterparty risk",
            "Collateral risk",
            "Complex index (daily leveraged)",
            "Roll costs/Contango or backwardation effects",
            "Explicit comprehension alert in KID"
        ],
        "classification": "complex",
        "supporting_data": "The 'WisdomTree FTSE 100 2x Daily Leveraged' is classified as complex due to multiple factors. Firstly, it offers '2 times the daily performance' (leverage), which is achieved through the integral use of derivative instruments such as 'futures contracts referenced in the Benchmark'. The MiFID II rules and ESMA guidance (CESR/09-295, Para 7, and Annex I, Section 4) state that financial instruments that use derivatives for their core strategy are 'always complex' because their value is derived from another financial instrument or asset, adding a level of complexity to understanding. The explicit mention of 'rolling' of futures contracts implies exposure to contango or backwardation effects, which are complex concepts not easily understood by a retail investor with basic knowledge. Although the KID doesn't explicitly name 'swaps', the description of providing 'total return' through a 'collateralised debt security' for leveraged exposure strongly indicates a synthetic replication method often involving swaps or similar total return instruments, which by definition introduces counterparty and collateral risks. The product itself carries a 'Comprehension Alert' in its KID, stating: 'You are about to purchase a product that is not simple and may be difficult to understand', which is a direct admission by the manufacturer of its complexity. Furthermore, the daily reset of the leverage factor leads to a 'compounding effect' over periods longer than one day, causing the product's performance to deviate significantly from the simple multiple of the index, a concept deemed difficult for the average retail investor to grasp. While the product is 'UCITS eligible', its inherent structural features and risks, particularly the integral use of derivatives for leverage and synthetic replication, override the general UCITS presumption of non-complexity under MiFID II. The intended retail investor is explicitly stated as requiring 'specific knowledge or experience of investing in similar products and in financial markets', further supporting the complex classification."
    }
}